中文摘要：

目的研究肺俞穴点刺放血治疗呼吸道感染的临床疗效,指导临床选用治疗呼吸道感染最佳方案。方法选取2012年1-12月进行诊治的呼吸道感染患者60例,随机分为两组,对照组30例患者中血常规白细胞高的给予口服头孢氨苄,对青霉素过敏患者口服罗红霉素胶囊治疗;治疗组患者30例在对照组治疗的基础上,进行肺俞穴用采血针点刺后拔罐放血,出血量为3ml,拔罐时间10min,对两组治疗进行对比分析,所有数据采用SPSS13.0进行分析。结果治疗48h后患者总有效率治疗组为93.3%、对照组为70.0%;治疗组的总有效率明显高于对照组,差异有统计学意义（P〈0.05）;患者平均退热时间治疗组为（20.1±12.38）h、对照组为（28.5±16.42）h;治疗组患者的平均退热时间明显低于对照组,差异具有统计学意义（P〈0.05）。结论肺俞穴点刺放血结合西医常规内科治疗呼吸道感染具有好的疗效,且不良反应发生率低,应作为常规治疗方案在临床推广。

英文摘要：

OBJECTIVE To study the clinical effects of using blood-vessel pricking on Feishu point in the treatment of respiratory infections,and to guide the clinical use of the optimal regimen in the treatment of respiratory tract infections.METHODS A total of 60 cases of patients with respiratory infections were chosen,and randomly divided into two groups.For the 30 patients in the control group,those with high leukocyte count in blood routine examination were administered with oral cefalexin,and those allergic to penicillin were treated with oral roxithromycin capsules.For the 30 patients in the treatment group,in addition to the treatment received in the control group,they were treated with blood-vessel pricking on Feishu point.The amount of hemorrhage was 3ml,and the duration of cupping therapy was 10 min.The two groups were then comparatively analyzed,and all the data were analyzed using SPSS13.0.RESULTS The total effective rate of the treatment group was 93.3% after 48 htreatment,and the total effective rate of the control group was 70.0% after 48 htreatment.The total effective rate in the treatment group was significantly higher than that of the control group,the difference was significant（P0.05）.The average defervescence time was（20.1±12.38）h for the treatment group,and（28.5±16.42）hours for the control group.The average defervescence time of patients in the treatment group was significantly lower than that in the control group（P0.05）.CONCLUSION Blood-vessel pricking on Feishu point combined with the routine internal medicine treatment had good clinical effects on respiratory infection,with low incidence of adverse reactions.This treatment measure should be used as a routine treatment in the clinic.